Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Access the Mets beat like never before Join Post Sports+ for exciting subscriber-only features, including real-time texting ...